Search for: "TAKEDA PHARMACEUTICAL COMPANY LIMITED" Results 1 - 20 of 43
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Feb 2024, 2:00 pm
Some propositions, moreover, are too particular, too new, or of too limited interest to be published. [read post]
15 Feb 2024, 9:05 pm by Jordan Lassiter
Food and Drug Administration (FDA) approved Takeda Pharmaceutical’s therapy, Eohilia, for treating eosinophilic esophagitis—a chronic condition characterized by inflammation of the esophagus. [read post]
Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals International AG, and Takeda Pharmaceuticals America, Inc.) sued to enjoin Defendants from marketing generic versions on the basis of inducing and/or contributorily infringing various patents, including U.S. [read post]
7 Dec 2023, 1:47 pm by Dennis Crouch
Teva Pharmaceuticals USA, Inc., 7 F.4th 1320, 1333 (Fed. [read post]
19 Dec 2019, 9:41 am
  Teva (and a merry band of other generic companies) argued that the '894 Patent did not protect this combination product under Article 3(a) of the SPC Regulation. [read post]
10 Sep 2019, 3:31 pm
' | Enlarged Board of Appeal in G 1/18 | Beyond exclusion of pharmaceutical products from patentable subject matter as a solution to limited access to medicines in Africa | ‘Cartography and Copyright’ | Warhol v Goldsmith: fairness of use by iconic artwork adjudicated in New York. | English High Court raises eyebrows over request to disclose ISP customer data | The EU Regulation on fairness in the platform economy is a let down for intellectual property | Vallenato… [read post]
26 Aug 2019, 12:09 pm
' | Enlarged Board of Appeal in G 1/18 | Beyond exclusion of pharmaceutical products from patentable subject matter as a solution to limited access to medicines in Africa | ‘Cartography and Copyright’ | Warhol v Goldsmith: fairness of use by iconic artwork adjudicated in New York. | English High Court raises eyebrows over request to disclose ISP customer data | The EU Regulation on fairness in the platform economy is a let down for intellectual property | Vallenato… [read post]
13 Aug 2019, 6:03 am
Thomas Key, in SportFuel is running empty after losing appeal: US 7th Circuit Court affirms that Gatorade’s slogan “Gatorade The Sports Fuel Company” is fair use, reports on the decision of the US 7th Circuit Court in SportFuel, Inc. v. [read post]
1 Aug 2019, 2:14 am
Earlier this year, the UK courts considered the validity of Genentech's patent for Taltz, an anti-IL-17 monoclonal antibody (IPKat post here), and last month, the courts considered Pfizer's request for an Arrow declaration relating to Roche's monoclonal antibody drug Avastin (bevacizumab) (IPKat post here).The latest UK High Court patent decision (Takeda v Roche [2019] EWHC 1911) relates to another pair of pharmaceutical company giants… [read post]
29 Apr 2019, 1:55 pm by Tom Lamb
Those drug injury lawsuits allege that the drug company Takeda failed to warn Uloric users about the increased risks of heart attacks and strokes. [read post]
7 Feb 2019, 6:00 am by Monica Wong (Toronto)
The most prominent of these deals was the takeover of Shire plc by Takeda Pharmaceutical Company Limited. [read post]
6 Aug 2018, 11:50 am by James Innocent
Developed by Takeda Pharmaceutical Company (Takeda) in the late 1990’s, pioglitazone (the main ingredient of Actos) was approved by the FDA in 1999 as a once-daily supplement to diet and exercise for the treatment and control of type 2 diabetes symptoms. [read post]
1 Dec 2017, 11:35 am by Nate Nead
Bard in Q2 2017 helped increase the value of deals.[27] Takeda Pharmaceutical Company acquired ARIAD Pharmaceuticals Inc for $5.2 billion to expand its oncology business. [read post]
15 Nov 2017, 8:00 am by Robert Kreisman
District Court Rules That Attorney-Client Privilege Applied in Insurance Coverage Lawsuit $9 Billion Actos Damage Award Against Takeda and Lilly is Upheld $90 Million Settlement Paid by Pharmaceutical Company For Its Unfair and Deceptive Promotion of Diabetes Drug The post U.S. [read post]
23 Nov 2015, 8:00 am by Robert Kreisman
Janssen Pharmaceuticals Inc., Johnson & Johnson Company and Johnson Pharmaceutical Research and Development, LLC, No. 130401990, Philadelphia County, Court of Common Pleas (Nov. 11, 2015). [read post]
21 May 2015, 4:29 am by Derek T. Braslow
Takeda Pharmaceutical Co. is attempting to settle nearly 8,000 Actos lawsuits across the United States by agreeing to pay $2.3 billion. [read post]
29 Apr 2015, 6:35 am by Dr. Shezad Malik
Takeda Pharmaceutical Co. has announced today that it will pay more than $2.4 billion to settle the pending Actos lawsuits over bladder cancer claims. [read post]
2 Apr 2015, 7:32 am by Joe Consumer
  Takeda Pharmaceuticals, Asia’s largest drugmaker, has offered to pay more than $2.2 billion to settle claims that it hid the cancer risks associated with its Actos diabetes medicine. [read post]